{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2018, Part 3

Purpose of Activity

To provide information about select drugs recently approved by the FDA.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe the indications for selected new drugs.
  2. Identify nursing implications for these new drugs.
Price: $17.95

Credits:

  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: N1018A
Published: Oct 2018
Expires: 9/4/2020
Sources: Nursing2019
Passing Score: 13/18 (72%)
Authors: Daniel A. Hussar, PhD
Topics: Drug Update